These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 5140093)

  • 41. Comparison of amantadine, placebo, and levodopa in Parkinson's disease.
    Bauer RB; McHenry JT
    Neurology; 1974 Aug; 24(8):715-20. PubMed ID: 4858417
    [No Abstract]   [Full Text] [Related]  

  • 42. A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel).
    Merrick EM; Schmitt PP
    Curr Ther Res Clin Exp; 1973 Aug; 15(8):552-8. PubMed ID: 4200529
    [No Abstract]   [Full Text] [Related]  

  • 43. The therapeutic possibilities of L-dopa and amantadine in Parkinsonian patients who have undergone bilateral thalamotomy.
    Giuffrè R; Gambacorta D
    Eur Neurol; 1971; 5(5):311-6. PubMed ID: 4943872
    [No Abstract]   [Full Text] [Related]  

  • 44. [Action of amantadine in extrapyramidal syndromes caused by neuroleptics].
    Fanali A; Nardini M; Sorgona F
    Sist Nerv; 1970; 22(5):273-85. PubMed ID: 5514245
    [No Abstract]   [Full Text] [Related]  

  • 45. [Current medical treatment of Parkinsonian syndromes].
    Cincă I; Bulandra R; Serbănesco A; Ninosu N
    Rev Roum Neurol; 1973; 10(4):257-85. PubMed ID: 4767886
    [No Abstract]   [Full Text] [Related]  

  • 46. [Therapy and problems of parkinsonism].
    Albert E
    Nervenarzt; 1971 May; 42(5):225-41. PubMed ID: 4942900
    [No Abstract]   [Full Text] [Related]  

  • 47. [Amantadine. Prolonged clinical trial in 50 parkinsonian patients].
    Castaigne P; Laplane D; Dordain G
    Nouv Presse Med; 1972 Feb; 1(8):533-6. PubMed ID: 5012351
    [No Abstract]   [Full Text] [Related]  

  • 48. L-dopa and amantadine hydrochloride in Parkinson's disease.
    Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment of Parkinson's disease with amantadine].
    Sigwald J; Raymondeaud C; Grégoire J
    Therapeutique; 1972 Nov; 48(9):555-60. PubMed ID: 4568230
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)].
    Schneider E; Fischer PA; Jacobi P
    Med Klin; 1974 Mar; 69(13):541-5. PubMed ID: 4831456
    [No Abstract]   [Full Text] [Related]  

  • 51. [Accomplishment of the treatment and evaluation of treatment alternatives in parkinsonism].
    Presthus J
    Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2119. PubMed ID: 4773985
    [No Abstract]   [Full Text] [Related]  

  • 52. [Iron, transferrin, copper and ceruloplasmin of the serum and cerebrospinal fluid in extrapyramidal diseases and primary myopathies. Study in basic conditions and in Parkinsonism after treatment with dopaminergic agents (L-dopa, L-dopa + RO 4-4602, amantadine)].
    Campanella G; Carrieri P; Romito D; Pasqual-Marsettin E
    Acta Neurol (Napoli); 1973; 28(1):1-34. PubMed ID: 4704396
    [No Abstract]   [Full Text] [Related]  

  • 53. [Quantitative testing methods for objectification of the effect of prolonged L-dopa therapy in parkinsonism].
    Gerstenbrand F; Grünberger J; Schubert H
    Nervenarzt; 1973 Aug; 44(8):428-33. PubMed ID: 4733895
    [No Abstract]   [Full Text] [Related]  

  • 54. [Drug therapy of Parkinson's diseases].
    Lhermitte F; Degos CF
    Acquis Med Recent; 1972; ():73-80. PubMed ID: 4667798
    [No Abstract]   [Full Text] [Related]  

  • 55. Levodopa and related drugs.
    Med Lett Drugs Ther; 1973 Mar; 15(5):21-3. PubMed ID: 4697470
    [No Abstract]   [Full Text] [Related]  

  • 56. [Kr 339 in the treatment of parkinsonian tremor].
    Iivanainen M
    Duodecim; 1974; 90(8):590-6. PubMed ID: 4605767
    [No Abstract]   [Full Text] [Related]  

  • 57. [Current therapeutic problems of the parkinson syndrome].
    Völler GW; Kapp W
    Med Welt; 1971 Aug; 33():1280-2. PubMed ID: 5566844
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of Parkinson's disease with L-dopa. 77 cases].
    Boudin G; Castaigne P; Lhermitte F; Beck H; Guillard A; Marteau R; Pepin B; Rondot P; Raphy B
    Rev Neurol (Paris); 1970 Feb; 122(2):89-102. PubMed ID: 4931719
    [No Abstract]   [Full Text] [Related]  

  • 59. KR 339 in the treatment of Parkinsonian tremor.
    Iivanainen M
    Acta Neurol Scand; 1974; 50(4):469-77. PubMed ID: 4604665
    [No Abstract]   [Full Text] [Related]  

  • 60. The comparative value of amantadine and levodopa.
    Dallos V; Heathfield K; Stone P; Allen F
    Postgrad Med J; 1972 Jun; 48(560):354-8. PubMed ID: 4558895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.